Applied Quantum Chemistry for Oncology
Triplet State Technology is a late stage developmental company pursuing innovative technology to improve cancer treatment outcomes.
Triplet State’s proprietary technology has general application to radiation therapy and selective application in cancer chemotherapy. The technology is based on fundamental and proven quantum chemistry and employs a structured low intensity magnetic field to alter free radical dynamics in treated tumor tissue. The technology as applied to human and animal tissues is patented.
Triplet State Technology has partnered with UCLA, RadiaBeam Technology of Santa Monica, California and HDA Technology of Lake Forest, CA to develop the technology. Cell culture and animal studies have demonstrated a 38% increase in cell kill in cancer tissue when the method is employed in conjunction with standard radiotherapy protocols.
Over the typical course of today's clinical standard in radiation treatment (30 irradiations given over six weeks), our use of electric and magnetic fields (EMF) + radiation will improve tumor kill by more than 50% over treatment with radiation alone.
The best way to look at the data is that our approach [EMF +
radiation] increases the delay in tumor growth by almost as much
as twice radiation treatment alone.
A 20% to 30% improvement will likely be adopted quickly and could become the new standard of care within 3-5 years
Previous
Next
